Search hospitals > Michigan > Ann Arbor

University of Michigan Comprehensive Cancer Center

Claim this profile
Ann Arbor, Michigan 48109
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
856 reported clinical trials
60 medical researchers
Photo of University of Michigan Comprehensive Cancer Center in Ann ArborPhoto of University of Michigan Comprehensive Cancer Center in Ann ArborPhoto of University of Michigan Comprehensive Cancer Center in Ann Arbor

Summary

University of Michigan Comprehensive Cancer Center is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Prostate Cancer and other specialties. University of Michigan Comprehensive Cancer Center is involved with conducting 856 clinical trials across 653 conditions. There are 60 research doctors associated with this hospital, such as Paul Swiecicki, Rashmi Chugh, MD, Vaibhav Sahai, MBBS, MS, and Francis P. Worden.

Area of expertise

1Parotid Gland Cancer
Global Leader
University of Michigan Comprehensive Cancer Center has run 155 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
University of Michigan Comprehensive Cancer Center has run 99 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at University of Michigan Comprehensive Cancer Center

Breast Cancer
Parotid Gland Cancer
Cancer
Pancreatic Cancer
Breast cancer
Ovarian Cancer
Lung Cancer
Lymphoma
Prostate Cancer
Skin Cancer
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Michigan Comprehensive Cancer Center?
Where is University of Michigan Comprehensive Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Michigan Comprehensive Cancer Center accept?
What awards or recognition has University of Michigan Comprehensive Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security